ADORA2A and neoplasm: Furthermore, correlation analyses between ADORA2A-AS1 expression and clinicopathological characteristics revealed that low ADORA2A-AS1 expression was associated with advanced American Joint Committee on Cancer (AJCC) pathologic t stage and pathologic tumor stage (Table 2).